HIV molecular immunology database

 

Patient Detail

Patient Code PC64 (PCT64)
Patient Sex
Risk Factor
Infection Country RW
Infection City
Infection Year 2008
HLA Type
Patient Ethnicity
Progression
Species human
Patient Note Source of PCT64 lineage. The donor was enrolled in the IAVI Protocol C longitudinal primary infection cohort approximately 2 weeks after infection by a subtype A1 HIV-1 virus, and was identified as an elite neutralizer [Landais2017].
CTL CD8+ Records
T-Helper CD4+ Records
Antibody Records PCT64-13C (3866), PCT64-13D (3867), PCT64-13E (3868), PCT64-13F (3869), PCT64-13G (3870), PCT64-13H (3871), PCT64-18A (3872), PCT64-18B (3873), PCT64-18C (3874), PCT64-18D (3875), PCT64-18F (3876), PCT64-24A (3877), PCT64-24B (3878), PCT64-24E (3879), PCT64-24F (3880), PCT64-24G (3881), PCT64-24H (3882), PCT64-35A (3883), PCT64-35B (3884), PCT64-35C (3885), PCT64-35D (3886), PCT64-35E (3887), PCT64-35F (3888), PCT64-35G (3889), PCT64-35H (3890), PCT64-35I (3891), PCT64-35K (3892), PCT64-35M (3893), PCT64-35N (3894), PCT64-35O (3895), PCT64-35S (3896), polyclonal PC64-M35 (3968)
Sequence Database Patient ID Record 108869
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health